GENEDX HOLDINGS CORP. reports a Return on Equity (ROE) of -30.62%.

What is WGSWW's dividend yield?

GENEDX HOLDINGS CORP. offers a dividend yield of 0.00%.

What is WGSWW's Deepscope Quality Score?

Deepscope rates WGSWW's overall financial quality at 46 out of 100, based on profitability, growth, debt and earnings stability.

Is now a good time to buy WGSWW?

Deepscope's AI Timing Score for WGSWW is 1 out of 100, indicating the relative attractiveness of buying at the current price using technical and momentum signals.

WGSWW (NASDAQ) 株価分析 | GENEDX HOLDINGS CORP.

Stock Check Daily update data at 9:30 AM
(Price: 2026-06-03 | FS: 2026-03-31)

WGSWW

GENEDX HOLDINGS CORP.

US:NASDAQ STOCK News 99

USD 0.01

-0.00 (-32.98%) Day Change

Watchlist Portfolio Compare Chart

0.40

D/E

-30.6%

ROE

-15.4%

ROA

0.00%

Div Yield

GENEDX HOLDINGS CORP.
TYPE: STOCK
MARKET: NASDAQ

Compare Watchlist Myport

USD 0.01 Price -0.00 (-32.98%) Day Change	NEWS SCORE: 99

WGSWW, ファンダメンタルスコアはnot good ( ファンダメンタル = 46) そしてテクニカルスコアは ...(Sign In to See)...

Loading chart...

46 QUALITY

Signal: UNDERPERFORM

Signal Description: Company financial health is Not Good

Reason: ROEが低い
ROAが低い
平均ROEが低い
ROEが昨年度比で低い
昨年度のROAが一昨年比で低い
NPMが低い
NPMの伸びが低い

88 Sign in

TIMING

Signal: OUTPERFORM

Signal Descri...: Good

Reason: Lorem ipsum dolor sit amet

Unlock timing signals and detailed reasons

In details, quality factors are not good , financial health is not good , and ability to make profit is ok , ...

Deepscope 分析

44%

In Recommendations?	Not in any sections
Select Rate	0.00 From 30 days period
Watch Rate	0.00 From 30 days period
News Score	99
Magic Formula Rank by ROA	N/A
Magic Formula Rank by ROE	N/A
Magic Formula Rank by ROIC	N/A
Price	0.01
PBV / Sector	N/A / N/A
Earning Per Share	N/A

PE / Sector	N/A / N/A
PEG or PE/Growth / Sector	N/A / N/A
Average 1M Daily Value	879.855120000000
Average 1W Daily Value	787.108540000000

Timing Factors

42%

MACD	SIGN IN
MACD Signal	SIGN IN
MACD Divergence	SIGN IN
RSI	SIGN IN
Stochastic Oscillator K	SIGN IN
Stochastic Oscillator D	SIGN IN
ADX	SIGN IN
Avg 5 day Timing Score	SIGN IN

Financial Health

45%

DE / Sector	SIGN IN
DE Average / Sector	SIGN IN
DE Change Average (%) / Sector	SIGN IN
Current Ratio / Sector	SIGN IN
Current Ratio Average / Sector	SIGN IN
Current Ratio Change Average (%) / Sector	SIGN IN
Quick Ratio / Sector	SIGN IN
Quick Ratio Average / Sector	SIGN IN
Quick Ratio Change Average (%) / Sector	SIGN IN
FCF/Share / Sector	SIGN IN
FCF/Share Average / Sector	SIGN IN
FCF/Share Change Average (%) / Sector	SIGN IN

ポイントになる統計

60%

GPM (%) / Sector	SIGN IN
GPM Average (%) / Sector	SIGN IN
GPM Change Average (%) / Sector	SIGN IN
OPM (%) / Sector	SIGN IN
OPM Average (%) / Sector	SIGN IN
OPM Change Average (%) / Sector	SIGN IN
NPM (%) / Sector	-17.58 / N/A
NPM Average (%) / Sector	-72.06 / N/A
NPM Change Average (%) / Sector	10.76 / N/A GOOD
Asset Turnover / Sector	SIGN IN
Asset Turnover Average / Sector	SIGN IN
Asset Turnover Change Average (%) / Sector	SIGN IN
ROA (%) / Sector	-15.37 / N/A
ROA Average (%) / Sector	-34.84 / N/A
ROA Change Average (%) / Sector	29.45 / N/A GREAT
ROE (%) / Sector	-30.62 / N/A
ROE Average (%) / Sector	-70.45 / N/A
ROE Change Average (%) / Sector	36.04 / N/A GREAT
ROIC (%) / Sector	SIGN IN
ROIC Average (%) / Sector	SIGN IN
ROIC Change Average (%) / Sector	SIGN IN

配当

Dividend (%) / Sector	N/A / N/A
Dividend Average (%) / Sector	N/A / N/A
Dividend Change Average (%) / Sector	N/A / N/A

登録情報

Analyze Date	2026-06-04 09:24:02
Symbol	WGSWW
Name	GENEDX HOLDINGS CORP.
Sector
Market	NASDAQ
Listed Shares	0.00
Par Value	N/A
Calculated From	Quarter
Sign	N/A
Market Cap (M.USD) / Sector Average	N/A / N/A

ニュース

Estimation Consensus	See at WSJ.com
Full details	See at WSJ.com
Chart	See in Chart feature
News	See at Yahoo Finance

Address: North Tower, Stamford, CT, United States, 06902

Phone: 888 729 1206

Website: https://www.genedx.com

Employees: 1,300

Sector: -

Description: GeneDx Holdings Corp., a genomics company, provides genetic testing services. The company primarily offers pediatric and rare disease diagnostics with a focus on whole exome and genome sequencing, as well as data and information services. It also develops an AI-based platform for next generation sequencing analysis, interpretation, and clinical reporting for rare disease, hereditary risk, and cancer testing. GeneDx Holdings Corp. was founded in 2000 and is headquartered in Stamford, Connecticut.